Back
Kimberly - Clark de Mexico SAB de CV Vs. Viking Therapeutics Industry Stock Comparison
Buy
70
KCDMY
Kimberly - Clark de Mexico SAB de CV
Last Price:
8.14
Seasonality Move:
-3.85%
Buy
82
VKTX
Viking Therapeutics
Last Price:
67.35
Seasonality Move:
18.67%
Buy
70
Kimberly - Clark de Mexico SAB de CV (KCDMY)
is a Buy
Is Kimberly - Clark de Mexico SAB de CV a Buy, Sell or Hold?
- The current Kimberly - Clark de Mexico SAB de CV [KCDMY] share price is $8.25. The Score for KCDMY is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- KCDMY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
82
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $66.73. The Score for VKTX is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
KCDMY Stock Price Chart
What is Kimberly - Clark de Mexico SAB de CV's stock price today?
-
The Kimberly - Clark de Mexico SAB de CV share price today is $8.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KCDMY is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $66.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
KCDMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 45.15 | Sell |
Chaikin Money Flow: | -13084 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.11 - 9.01) | Sell |
Bollinger Bands (100): | (8.42 - 10.28) | Sell |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.71 | Buy |
Relative Strength Index (14 RSI): | 62.15 | Buy |
Chaikin Money Flow: | 2021213 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.36 - 64.52) | Buy |
Bollinger Bands (100): | (51.88 - 68.82) | Buy |
KCDMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.12 | Buy |
20-day SMA: | 8.41 | Sell |
50-day SMA: | 8.76 | Sell |
200-day SMA: | 10.22 | Sell |
8-day EMA: | 8.19 | Buy |
20-day EMA: | 8.36 | Sell |
50-day EMA: | 8.73 | Sell |
200-day EMA: | 9.75 | Sell |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.44 | Buy |
20-day SMA: | 61.2 | Buy |
50-day SMA: | 57.74 | Buy |
200-day SMA: | 51.43 | Buy |
8-day EMA: | 60.69 | Buy |
20-day EMA: | 59.87 | Buy |
50-day EMA: | 58.91 | Buy |
200-day EMA: | 50.69 | Buy |
Kimberly - Clark de Mexico SAB de CV Earnings Growth & KCDMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
Kimberly - Clark de Mexico SAB de CV Technical Analysis
Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |